• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X 连锁溶酶体贮积症女性携带者的疾病表达:简要综述。

Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

机构信息

Postgraduate Program in Child and Adolescent Health, UFRGS, Porto Alegre, Brazil.

出版信息

Orphanet J Rare Dis. 2010 May 28;5:14. doi: 10.1186/1750-1172-5-14.

DOI:10.1186/1750-1172-5-14
PMID:20509947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2889886/
Abstract

Most lysosomal diseases (LD) are inherited as autosomal recessive traits, but two important conditions have X-linked inheritance: Fabry disease and Mucopolysaccharidosis II (MPS II). These two diseases show a very different pattern regarding expression on heterozygotes, which does not seem to be explained by the X-inactivation mechanism only. While MPS II heterozygotes are asymptomatic in most instances, in Fabry disease most of female carriers show some disease manifestation, which is sometimes severe. It is known that there is a major difference among X-linked diseases depending on the cell autonomy of the gene product involved and, therefore, on the occurrence of cross-correction. Since lysosomal enzymes are usually secreted and uptaken by neighbor cells, the different findings between MPS II and Fabry disease heterozygotes can also be due to different efficiency of cross-correction (higher in MPS II and lower in Fabry disease). In this paper, we review these two X-linked LD in order to discuss the mechanisms that could explain the different rates of penetrance and expressivity observed in the heterozygotes; this could be helpful to better understand the expression of X-linked traits.

摘要

大多数溶酶体贮积症(LD)为常染色体隐性遗传,但有两种重要的疾病为 X 连锁遗传:法布里病和黏多糖贮积症 II 型(MPS II)。这两种疾病在杂合子的表达模式上存在很大差异,这似乎不能仅用 X 染色体失活机制来解释。在大多数情况下,MPS II 杂合子无症状,但在法布里病中,大多数女性携带者表现出一些疾病表现,有时甚至很严重。已知 X 连锁疾病之间存在很大差异,这取决于所涉及的基因产物的细胞自主性,因此也取决于交叉校正的发生。由于溶酶体酶通常被分泌并被邻近细胞摄取,因此 MPS II 和法布里病杂合子之间的不同发现也可能是由于交叉校正的效率不同(MPS II 中较高,法布里病中较低)。本文综述了这两种 X 连锁 LD,以探讨可解释杂合子中观察到的不同外显率和表现度的机制;这有助于更好地理解 X 连锁性状的表达。

相似文献

1
Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.X 连锁溶酶体贮积症女性携带者的疾病表达:简要综述。
Orphanet J Rare Dis. 2010 May 28;5:14. doi: 10.1186/1750-1172-5-14.
2
Are MPS II heterozygotes actually asymptomatic? A study based on clinical and biochemical data, X-inactivation analysis and imaging evaluations.MPS II 杂合子实际上是否无症状?一项基于临床和生化数据、X 染色体失活分析和影像学评估的研究。
Am J Med Genet A. 2011 Jan;155A(1):50-7. doi: 10.1002/ajmg.a.33770.
3
Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.法布里病杂合子培养的皮肤成纤维细胞中缺乏α-半乳糖苷酶交叉校正。
Mol Genet Metab. 2015 Feb;114(2):268-73. doi: 10.1016/j.ymgme.2014.11.005. Epub 2014 Nov 12.
4
[Genetics of Fabry disease: diagnostic and therapeutic implications].[法布里病的遗传学:诊断和治疗意义]
Presse Med. 2007 Mar;36 Spec No 1:1S14-9.
5
X-chromosome inactivation in female patients with Fabry disease.法布里病女性患者的X染色体失活
Clin Genet. 2016 Jan;89(1):44-54. doi: 10.1111/cge.12613. Epub 2015 Jun 22.
6
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.法布里杂合子中X染色体失活与临床受累情况的关系。捷克和斯洛伐克人群中α-半乳糖苷酶A基因的11种新突变。
J Mol Med (Berl). 2005 Aug;83(8):647-54. doi: 10.1007/s00109-005-0656-2. Epub 2005 Apr 2.
7
The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey.法布瑞病、戈谢病和黏多糖贮积症 II 型患者的就医历程:一项德国范围内的电话调查。
PLoS One. 2020 Dec 31;15(12):e0244279. doi: 10.1371/journal.pone.0244279. eCollection 2020.
8
Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.安德森-法布里病:女性杂合子的疾病临床表现。
J Inherit Metab Dis. 2001 Dec;24(7):715-24. doi: 10.1023/a:1012993305223.
9
Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders.女性亨特综合征由单个突变和家族性 XCI 偏倚引起:对其他 X 连锁疾病的影响。
Clin Genet. 2011 Nov;80(5):459-65. doi: 10.1111/j.1399-0004.2010.01574.x. Epub 2010 Nov 10.
10
Mucopolysaccharidosis type II in females and response to enzyme replacement therapy.黏多糖贮积症 II 型在女性中的表现和酶替代治疗的反应。
Am J Med Genet A. 2012 Feb;158A(2):450-4. doi: 10.1002/ajmg.a.34415. Epub 2012 Jan 13.

引用本文的文献

1
Fabry disease in females: organ involvement and clinical outcomes compared with the general population (103/150 characters).女性法布里病:与普通人群相比的器官受累情况及临床结局(103/150字符)
Orphanet J Rare Dis. 2025 Aug 13;20(1):433. doi: 10.1186/s13023-025-03922-x.
2
X-linked competition - implications for human development and disease.X连锁竞争——对人类发育和疾病的影响
Nat Rev Genet. 2025 May 12. doi: 10.1038/s41576-025-00840-3.
3
The multifaceted challenges faced by women in the field of inherited metabolic disorders.

本文引用的文献

1
Clinical and biochemical studies in mucopolysaccharidosis type II carriers.黏多糖贮积症 II 型携带者的临床和生化研究。
J Inherit Metab Dis. 2009 Dec;32(6):732-738. doi: 10.1007/s10545-009-1275-9. Epub 2009 Oct 10.
2
Lysosomal disorders: from storage to cellular damage.溶酶体疾病:从储存到细胞损伤
Biochim Biophys Acta. 2009 Apr;1793(4):684-96. doi: 10.1016/j.bbamcr.2008.12.001. Epub 2008 Dec 8.
3
Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts.
患有遗传性代谢紊乱疾病的女性所面临的多方面挑战。
Orphanet J Rare Dis. 2025 Mar 5;20(1):104. doi: 10.1186/s13023-025-03604-8.
4
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study.法布里病脑血管改变的患病率及其临床关联:一项横断面研究
Brain Sci. 2025 Feb 7;15(2):166. doi: 10.3390/brainsci15020166.
5
Identification of Four New Mutations in the GLA Gene Associated with Anderson-Fabry Disease.与安德森-法布里病相关的GLA基因中四个新突变的鉴定。
Int J Mol Sci. 2025 Jan 8;26(2):473. doi: 10.3390/ijms26020473.
6
Genome-wide study of gene-by-sex interactions identifies risks for cleft palate.全基因组研究基因-性别相互作用鉴定腭裂风险。
Hum Genet. 2024 Nov;143(11):1341-1352. doi: 10.1007/s00439-024-02704-y. Epub 2024 Oct 3.
7
Impact of Replacement Therapy on Pregnancy Outcomes in Hemophilia Carriers: A Historical Cohort Study in Saudi Arabia.替代疗法对血友病携带者妊娠结局的影响:沙特阿拉伯的一项历史性队列研究
Life (Basel). 2024 May 11;14(5):623. doi: 10.3390/life14050623.
8
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.培加尼西酶阿尔法与阿加糖酶β在伴有肾功能恶化的法布雷病患者中的头对头试验:来自 2 年随机 III 期 BALANCE 研究的结果。
J Med Genet. 2024 May 21;61(6):520-530. doi: 10.1136/jmg-2023-109445.
9
Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family.经典法布里病的形态学特征:对一个西班牙大家族的超微结构研究
J Clin Med. 2023 Aug 31;12(17):5689. doi: 10.3390/jcm12175689.
10
Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?不明原因左心室肥厚(LVH)患者中诊断法布里病的困难:新的GLA基因突变是致病突变还是多态性?
Balkan J Med Genet. 2023 Jul 31;26(1):43-50. doi: 10.2478/bjmg-2023-0010. eCollection 2023 Jul.
异常的甘露糖-6-磷酸受体转运损害庞贝病成纤维细胞中重组α-葡萄糖苷酶的摄取。
Pathogenetics. 2008 Dec 1;1(1):6. doi: 10.1186/1755-8417-1-6.
4
Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease.疾病罕见性、携带者状态与性别:法布里病女性面临的三重不利因素
J Genet Couns. 2008 Dec;17(6):528-37. doi: 10.1007/s10897-008-9179-7. Epub 2008 Oct 16.
5
Clinical and genetic analysis of Fabry disease: report of six cases including three heterozygous females.法布里病的临床与遗传学分析:6例报告,包括3例杂合子女性
J Dermatol Sci. 2008 Oct;52(1):61-4. doi: 10.1016/j.jdermsci.2008.04.009. Epub 2008 Jun 13.
6
Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes.法布里病半合子和杂合子的非侵入性高危筛查。
Pediatr Nephrol. 2008 Sep;23(9):1461-71. doi: 10.1007/s00467-008-0846-6. Epub 2008 Jun 6.
7
Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.用于确定女性是否患有法布里病的酶活性检测会产生40%的假阴性结果。
J Am Coll Cardiol. 2008 May 27;51(21):2082; author reply 2082-3. doi: 10.1016/j.jacc.2008.02.050.
8
Elevated globotriaosylsphingosine is a hallmark of Fabry disease.高浓度的球三糖基鞘氨醇是法布里病的一个标志。
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7. doi: 10.1073/pnas.0712309105. Epub 2008 Feb 19.
9
Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease.日本法布里病杂合子女性的临床表现与自然病史。
J Inherit Metab Dis. 2008 Dec;31 Suppl 3:483-7. doi: 10.1007/s10545-007-0740-6. Epub 2008 Jan 21.
10
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.II型黏多糖贮积症(亨特综合征):酶替代疗法时代的临床综述与治疗建议
Eur J Pediatr. 2008 Mar;167(3):267-77. doi: 10.1007/s00431-007-0635-4. Epub 2007 Nov 23.